MedPath
FDA Product

Vasostrict

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Vasostrict

42023-164

Regulatory Information

42023-164

NDA204485

C73594

March 6, 2023

USA

These highlights do not include all the information needed to use VASOSTRICT safely and effectively. See full prescribing information for VASOSTRICT. VASOSTRICT (vasopressin injection) for intravenous useInitial U.S. Approval: 2014

HUMAN PRESCRIPTION DRUG LABEL

3

Company Information

092733690

Active Ingredients

SODIUM ACETATE

Quantity: 1.36 mg in 1 mL

Code: 4550K0SC9B

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

SODIUM HYDROXIDE

Code: 55X04QC32I

Class Code: IACT

VASOPRESSIN, UNSPECIFIED

Quantity: 20 [USP'U] in 1 mL

Code: Y87Y826H08

Class Code: ACTIB

HYDROCHLORIC ACID

Code: QTT17582CB

Class Code: IACT

Active Moieties

VASOPRESSIN, UNSPECIFIED

Code: Y87Y826H08

© Copyright 2025. All Rights Reserved by MedPath